Skip to content

Embecta Corp. EMBC Other Income (Expense)

Other Income (Expense) at other companies

Insulet logo
InsuletPODD
$700K+132%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$2.44M-102%
Medtronic logo
MedtronicMDT
$137M
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$110K
Mannkind logo
MannkindMNKD
-$14.7M-69.4%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
$2.38M+124%

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s other income (expense)?
Embecta Corp. (EMBC) reported other income (expense) of -$2.9M in Q1 2026.
How has Embecta Corp.'s other income (expense) changed year-over-year?
Embecta Corp.'s other income (expense) decreased by 625.0% year-over-year, from -$400K to -$2.9M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.